Trials Sponsors Conditions Drugs Pricing

Conditions

Prostate Cancer

Keywords

Prostate cancerContinuous androgen suppressionIntermittent androgen suppressionBone lossOsteoporosis

Eligibility Criteria

Age0 Years+

Sexall

Healthy VolunteersNo

Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

Histologically confirmed PCa
Completed radiotherapy to the prostatic area more than 12 months prior to randomization
Rising PSA level (serum PSA \> 3 ng/ml (3 μg/L)) and higher than the lowest level recorded previously since the end of radiotherapy (i.e. higher than the post-radiotherapy nadir)
No definite evidence of distant metastasis (radiological changes compatible with non-malignant diseases are acceptable)
No prior hormonal therapy with the exception of neo-adjuvant cytoreduction prior to radical radiotherapy or prostatectomy for a maximum duration of 12 months and completed at least 12 months prior to randomization.

Sponsors & Collaborators

Ontario Cancer Research Network
Research networklead

Study Sites (1)

Sunnybrook and Women's College Health Sciences Centre

Toronto, Ontario, M4N 3M5, Canada

RECRUITING

Marlene Kebabdjian, CRACONTACT416-480-6100 ext. 2890 marlene.kebabdjian@sw.ca

MeSH Terms

Conditions

Prostatic NeoplasmsBone Diseases, MetabolicOsteoporosis

Condition Hierarchy (Ancestors)

Genital Neoplasms, MaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsGenital Diseases, MaleGenital DiseasesUrogenital DiseasesProstatic DiseasesMale Urogenital DiseasesBone DiseasesMusculoskeletal DiseasesMetabolic Diseases

Study Officials

Laurence Klotz, MD, FRCSC
Sunnybrook Health Sciences Centre
PRINCIPAL INVESTIGATOR

Central Study Contacts

Laurence Klotz, MD, FRCSC

CONTACT

416-480-4673 laurence.klotz@sw.ca

Study Design

Study Type: observational
Time Perspective: OTHER
Sponsor Type: NETWORK

Study Record Dates

First Submitted

September 27, 2005

First Posted

September 28, 2005

Study Start

April 2004

Date type not reported

This date has not been verified as actual or estimated.

Study Completion

April 2008

Date type not reported

This date has not been verified as actual or estimated.

PR.7 Companion Trial: Effect of Intermittent Versus Continuous Androgen Suppression on Bone Loss and Body Composition

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

Study Start

First Submitted

First Posted

Study Completion

Conditions

Keywords

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Central Study Contacts

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Study Completion

Conditions

Keywords

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Central Study Contacts

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations